Medication info
Clopidogrel Tablets (Clopidogrel Bisulfate)

Clopidogrel Tablets (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Hwa-il Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201301620 · Approved 2013.01.18 · Insurance code 684500770

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
■ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, begin with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ∼100 mg should be administered concomitantly with this medicine once daily. ■ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ■ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Hwa-il Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • atherothrombosis
  • thromboembolism
View approved original text

This medication is used to improve symptoms associated with atherosclerosis related to ischemic stroke, myocardial infarction, and peripheral arterial disease. It also helps reduce the risk of death from cardiovascular abnormalities, myocardial infarction, stroke, and refractory ischemia in adult patients with acute coronary syndrome or those who have undergone related procedures. Additionally, it plays a role in reducing the risk of stroke and thromboembolism in patients with atrial fibrillation who have a low risk of bleeding, where vitamin K antagonist therapy is not appropriate. This medication is used to enhance patient health by improving risk factors due to various cardiovascular diseases and lesions.

How to take

Adult dose

■ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, begin with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ∼100 mg should be administered concomitantly with this medicine once daily. ■ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ■ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This medication is an antiplatelet agent that prevents platelets from aggregating, thus preventing blood clotting. Before taking this medication, it is essential to verify if there are individuals with genetically reduced functionality of a specific enzyme (CYP2C19). Individuals with impaired enzyme activity may not respond properly to this medication, potentially experiencing cardiovascular issues such as heart attacks or strokes more frequently. Additionally, using this medication along with drugs that activate the enzyme may lead to excessively high drug concentrations, increasing the risk of bleeding, so concurrent use is not recommended. This medication should not be used in individuals with certain diseases or allergies, those with bleeding issues, patients with very poor liver function, lactating women, and individuals with lactose intolerance. Patients with a risk of bleeding or a tendency to bleed should use this medication with caution, and it should be discontinued 5-7 days prior to any scheduled surgery. During treatment, if any bleeding symptoms (e.g., bruising, nosebleeds, gum bleeding) occur, medical personnel should be notified immediately. When taken with other drugs that increase bleeding risk, anticoagulants, nonsteroidal anti-inflammatory drugs, or selective serotonin reuptake inhibitors (SSRIs), the risk of bleeding may increase significantly, so caution is needed. During pregnancy, the safety of this medication for the fetus has not been adequately established; however, treatment should not be delayed in emergencies like myocardial infarction or stroke. If lactating, careful consideration should be given to whether to continue breastfeeding or to stop medication, as this drug can be excreted in breast milk. Elderly patients or those with impaired renal or liver function have a higher risk of bleeding, so dosage adjustment and careful monitoring according to a physician's instructions are necessary. In case of overdose, prolongation of bleeding time and bleeding complications may occur, requiring immediate treatment. Although there is no specific antidote for this medication, platelet transfusions can counteract the effect. This medication should be kept out of reach of children and should not be transferred to another container. While it is known that this medication does not significantly affect driving or operation of machinery, caution should be exercised if bleeding symptoms occur.

Side effects

Hemorrhage, gastrointestinal bleeding, hemorrhage requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major hemorrhage, minor hemorrhage, severe hemorrhage, fatal hemorrhage, hemorrhagic stroke, thrombocytopenia, neutropenia, aplastic anemia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decreased motor function, tremor, voice disorder, abnormal gait, hyperkinesia, ataxia, sensory disturbances, constipation, ulcer, loss of appetite, vomiting, hiccups, thirst, dysphagia, tongue disorders, insomnia, depression, amnesia, anxiety, dissociation, abnormal behavior, rigidity, weight loss, weight gain, facial flushing, weakness, facial edema, syncope, purpura syndrome, melena, cerebral hemorrhage, gingival bleeding, pneumonia, sinusitis, visual disturbances, visual field defects, dry eye syndrome, transient blindness, congestion, tinnitus, taste disturbances, urinary incontinence, polyuria, non-protein nitrogen increase, uremia, increased blood urea nitrogen, hypoglycemia, hyperuricemia, liver enzyme elevation, ALT increase, liver dysfunction, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, bloating, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, maculopapular rash, erythematous or exfoliative skin rash, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container as it may be sensitive to air or moisture. It is best to store it at room temperature, between 1 to 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.